Science 37
Mike Zaranek is the chief financial officer for Science 37, where he is responsible for all accounting and corporate finance functions as well as strategic pricing. He serves on the senior executive team.
Mike joins Science 37 from IQVIA's Contract Sales & Medical Solutions, where he served as vice president of finance for the global business unit, which had 2019 revenues of more than $800 million and operated in 30+ countries. In this role, Mike set the financial strategy, drove growth, and developed financial structures to enhance customer value. He was also responsible for financial planning and analysis, segment reporting, and led financial due diligence on prospective acquisition targets. Previously, Mike spent almost two decades in corporate development roles, where he drove inorganic growth as well as supported capital market transactions to fund growth, deliver shareholder returns, and optimize capital structure. In the aggregate, Mike has experience in excess of $20 billion in inorganic and capital market transactions.
This person is not in any offices
Science 37
2 followers
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.